| Product Code: ETC6354913 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Belgium continued to see a steady flow of import shipments of gram-positive bacterial infection treatments. Key exporting countries such as Italy, Germany, USA, Metropolitan France, and Switzerland played a significant role in supplying these essential products. With a moderate concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market remained competitive. The compound annual growth rate (CAGR) from 2020 to 2024 was a promising 6.34%, although there was a slight decline in growth rate from 2023 to 2024 at -0.43%. Overall, the outlook for the import market for gram-positive bacterial infection treatments in Belgium appears positive with steady growth.

| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Belgium Gram-positive Bacterial Infections Market Overview | 
| 3.1 Belgium Country Macro Economic Indicators | 
| 3.2 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Belgium Gram-positive Bacterial Infections Market - Industry Life Cycle | 
| 3.4 Belgium Gram-positive Bacterial Infections Market - Porter's Five Forces | 
| 3.5 Belgium Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F | 
| 3.6 Belgium Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F | 
| 3.7 Belgium Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F | 
| 3.8 Belgium Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Belgium Gram-positive Bacterial Infections Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of gram-positive bacterial infections in Belgium | 
| 4.2.2 Rising awareness about the importance of early diagnosis and treatment of bacterial infections | 
| 4.2.3 Technological advancements leading to the development of new and effective treatment options | 
| 4.3 Market Restraints | 
| 4.3.1 Antibiotic resistance posing a challenge in the treatment of gram-positive bacterial infections | 
| 4.3.2 High treatment costs associated with advanced therapies and medications | 
| 4.3.3 Stringent regulatory requirements for the approval of new antibiotics | 
| 5 Belgium Gram-positive Bacterial Infections Market Trends | 
| 6 Belgium Gram-positive Bacterial Infections Market, By Types | 
| 6.1 Belgium Gram-positive Bacterial Infections Market, By Drug Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F | 
| 6.1.3 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F | 
| 6.1.4 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F | 
| 6.1.5 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 Belgium Gram-positive Bacterial Infections Market, By Disease | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F | 
| 6.2.3 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F | 
| 6.2.4 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F | 
| 6.2.5 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F | 
| 6.2.6 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F | 
| 6.2.7 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F | 
| 6.3 Belgium Gram-positive Bacterial Infections Market, By Route of Administration | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F | 
| 6.3.3 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F | 
| 6.3.4 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F | 
| 6.4 Belgium Gram-positive Bacterial Infections Market, By Distribution Channel | 
| 6.4.1 Overview and Analysis | 
| 6.4.2 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F | 
| 6.4.3 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F | 
| 6.4.4 Belgium Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 Belgium Gram-positive Bacterial Infections Market Import-Export Trade Statistics | 
| 7.1 Belgium Gram-positive Bacterial Infections Market Export to Major Countries | 
| 7.2 Belgium Gram-positive Bacterial Infections Market Imports from Major Countries | 
| 8 Belgium Gram-positive Bacterial Infections Market Key Performance Indicators | 
| 8.1 Rate of antibiotic resistance development in gram-positive bacteria | 
| 8.2 Number of new treatment options and therapies introduced in the market | 
| 8.3 Percentage of healthcare professionals adopting guidelines for the management of gram-positive bacterial infections | 
| 9 Belgium Gram-positive Bacterial Infections Market - Opportunity Assessment | 
| 9.1 Belgium Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F | 
| 9.2 Belgium Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F | 
| 9.3 Belgium Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F | 
| 9.4 Belgium Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Belgium Gram-positive Bacterial Infections Market - Competitive Landscape | 
| 10.1 Belgium Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 | 
| 10.2 Belgium Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |